Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments ...

So I think that's also helped us this growth. And certainly, our two key drivers have been KEYTRUDA and GARDASIL. And when I look at KEYTRUDA back in 2019, internationally, we only had 12 indications.

The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...

Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...